Navigation Links
Major Gene Study Uncovers Secrets of Leukemia

ee so-called “master genes” that control the normal differentiation of immature progenitor cells into mature B lymphocytes.

The researchers found that the “PAX5” gene was most frequently mutated—altered in about 30 percent of patients. These mutations reduced the level of PAX5 protein in leukemic cells or resulted in the formation of PAX5 protein with defective function. Mutations were also found in other genes with important roles in B-cell differentiation including “EBF1” and “Ikaros.”

“Although the identification of such a high frequency of mutations in this pathway was surprising, it is important to note that the approach used provides a lower limit of the true frequency of these mutations, since not every gene in this pathway could be accurately analyzed using this methodology,” Downing said.

The mutations identified in “PAX5,” “EBF” and “Ikaros” are likely to directly contribute to this block in normal lymphocyte differentiation, according to Downing. These genes encode proteins called transcription factors, which orchestrate the expression of a large number of other genes involved in B cell development. Together these genes coordinate the complex changes needed to induce progenitor cells to differentiate into B lymphocytes. In ALL, the leukemic cells fail to differentiate normally and instead remain blocked at an immature stage of development. Locked in this state, the leukemic cells continue to proliferate, and this continual growth of leukemic cells eventually kills the child.

“The new insights into the differentiation of B cells are extremely valuable,” said Ching-Hon Pui, M.D., chair of the Oncology department and American Cancer Society Professor at St. Jude. Pui co-authored the paper. “The more we learn about why progenitor cells get stuck in the primitive, cancerous stage, the more likely we’ll be able to design new therapies that eliminate them. That could help us continue our successful efforts to incre
'"/>




Page: 1 2 3

Related medicine news :

1. First Artificial Heart patient has Major setback
2. Vision Loss Due To Diabetic Retinopathy a Major Cause Of Concern
3. Depression Found To Be A Major Cause for Death in Elderly
4. Genetics Has A Major Role To Play In Body Shape.
5. Pigs Population A Major Threat To Encephalitis Ravaged UP
6. Delhi Government To Interlink All Major Hospitals Through e-Governance
7. Nine Major Culprits For Tooth Loss Identified By Researchers
8. Obesity Among Children May Become a Major Problem
9. Canadian Lung Cancer Study Lauded As Major Advance in Cancer Fight
10. Smokers Sue Tobacco Major Philip Morris
11. India Can Become Major HIV Drugs Producer
Post Your Comments:
(Date:10/13/2008)... Patients Earning Under $40,000 Annually Say They ...d Care, ANN ARBOR, Mich., Oct. 13 /PRNewswire/ --...announced the publication of a new research report...reatment decisions of,individuals., Entitled "The...ponses,from 1,767 adults currently being treated f...
(Date:10/13/2008)...sists even after weekly doses up to 3 times recomm...Day News) -- Existing guidelines for treating vita...are too low and put patients at high risk for bone...ers from Johns Hopkins Children,s Center looked at...lf the children were vitamin D-deficient, and most...
(Date:10/13/2008)...ut Docu-Series Follows Three Women ...They Deliver High-Risk Babies in Their OB/GYN Prac...-- Discovery Health is going,back into the deliver...it,docu-series, DELIVER ME. The breakout series fo...e Bohn, Allison Hill and Alane Park -- best,friend...
(Date:10/13/2008)...wswire/ -- The Beryl Companies, a,healthcare-exclu...roplex,was included in the Inc. 5000 list of the ...or the second straight year. Beryl has achieved a ...s., The Inc. 5000 list is the most comprehensive ...- America,s independent-minded entrepreneurs. Take...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Survey Finds Cancer Patients Forgoing Treatment Because of Cost 2Health News:Vitamin D Guidelines Too Low for Cystic Fibrosis Kids 2Health News:Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT 2Health News:Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT 3Health News:The Beryl Companies Named to Inc. 5000 List for Second Consecutive Year 2
...A new study published in the journal, Molecular Ps... a genetic marker which may make people susceptibl...der and affects around half of young children and ...is harmless, it may sometimes cause injuries to th...
...Former smokers constitute almost half of all newly...ious damage to the lungs that do not disappear as ...ue to recover. It has also been found that smoking...gene that could protect cells from becoming cancer...
...A research project carried out by Juliette van den...at new bone cells can be grown into bone fractures... and bone marrow cells. Researchers inserted a tit...t. They allowed bone marrow cells to grow on this....
...A new study published in the British Medical Journ...ng colorectal cancers at an early stage could be a...chers claimed that nine out of ten bowel and colon...ed and that once the cancer has spread cure rates ...
Other Medicine News:Health News:Bones repair themselves with bone marrow cells 2
(Date:10/10/2008)...s., Oct. 10 /- Inverness Me...rovider of near-patient,diagnostics, monitoring an...Ban Ki-moon, the Secretary-General of the United N... seventeen of the world,s leading,research-based a....,Inverness, together with senior officials from t...
(Date:10/9/2008)...an Campaign to Spread Awareness and Bring Hope to .../PRNewswire-USNewswire/ -- 133 million children,ac...uses such as natural,disaster, civil war, and dise...rving World Orphan Week by calling attention to th...edia News Release, go to:, http://www.prnewswire...
(Date:10/9/2008)...nical Results Expected in November 2008, BOTHELL,...rma, Inc.,(Amex: DDD ) announced today the comple...d of its three pivotal trials to evaluate the safe...nded-release (ER) ibuprofen for,the over-the-count...-line,results from this pivotal trial in November ...
(Date:10/8/2008)...Va., Oct. 8 /PRNewswire-USNewswire/ -- The facts a...e from HIV/AIDS in,sub-Saharan Africa. More than 3...Africa have already died of AIDS. The Foundation f...sure the dying and their families,find compassion ...A,s,innovative partnering initiative links African...
Breaking Medicine Technology:Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 1Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 2Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 3Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 4Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 5Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 6Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 7Synvista Therapeutics to Present at Acumen BioFin Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5320 1Synvista Therapeutics to Present at Acumen BioFin Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5320 2Synvista Therapeutics to Present at Acumen BioFin Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5320 3APIC Recommendations on Infection Prevention in Long Term Care Facilities 19075 1APIC Recommendations on Infection Prevention in Long Term Care Facilities 19075 2Neuralstem Responds to New StemCells Inc Lawsuit 5315 1Neuralstem Responds to New StemCells Inc Lawsuit 5315 2
...TER, Colo., April 19, 2007 /PRNewswire-FirstCall/ ...he Commission of the,European Communities, with a ...cinal Products of the European Medicines Agency (E...ompany,s novel,antifolate PDX (pralatrexate) for t...mphoma (PTCL). In July 2006, the U.S. Food and,Dru...
... time to pain progression is 66.1 weeks for the,sa...cebo arm --,Hazard ratio of 0.64 (95% CI: 0.51-0.7...elative risk of pain progression, MARTINSRIED/MUNI...- PRINCETON, N.J., and BOULDER, Colo. -- GPC Biote... presentation of additional,data from the double-b...
Other Medicine Technology:Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 2Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 3Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 4Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 5Additional Efficacy Data from Satraplatin SPARC Phase 3,Investigational Trial Presented at Annual Meeting of American,Urological Association 6
The BioCheck LH ELISA is intended for the quantitative determination of luteinizing hormone (LH) in human serum. This assay is useful in the diagnosis and treatment of gonadal dysfunction.
...tein secreted by the anterior pituitary gland. Lik...a noncovalently-linked dimer containing alpha- and...ogous alpha-subunits, however each hormone has a u... secretion are stimulated by gonadotropin-releasin...
Microwell-EIA for the detection of Insulin Autoantibody.
An integrated color touch screen shows you the way and with its single-use sensor cassette it is ready-to-go in any situation. The calibration gas bottle assures accurate calibration prior to each s
Medicine Products: